Germany: Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of high-risk artificial intelligence (AI) systems under the EU Artificial Intelligence Act (AI Act).

European Union Healthcare

GT

Greenberg Traurig, LLP

Second Medical Use Claims In The UPC System: Prerequisites And Mechanism Of Examination For Infringement

The Local Division of Düsseldorf is the first UPC panel to set out the prerequisites and establish essential factors for assessing infringement of second medical use claims in the UPC system. Its approach builds on the criteria developed by national (German) courts.

Germany Healthcare

BP

Bardehle Pagenberg

New German Government: Key Plans For The Life Sciences And Healthcare Sector

Following the election in February, the party leaderships of CDU, CSU and SPD have agreed on a coalition agreement titled "Responsibility for Germany".

Germany Healthcare

AO

A&O Shearman

New CJEU Ruling On The Borderline Between Medicinal Products And Medical Devices: Key Takeaways

The boundary between medicinal products and medical devices remains a recurring issue for companies developing or marketing borderline products and courts, which has already been the subject of numerous decisions.

Germany Healthcare

AO

A&O Shearman

Wind Of Change - Are Medical Sick Leave Certificates Still Untouchable?

Germany Healthcare

L

Littler

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025

European Union Healthcare

AO

A&O Shearman

Council Approves EU Packaging Regulation ‒ Introduction Of Standardised Legal Framework For Entire Packaging Life Cycle And New Challenges For Market Participants

Germany Healthcare

N

Noerr

The Digital Act: A Boost For Digitalisation In German Healthcare

Germany Healthcare

GL

Gleiss Lutz

Bundestag Debates Government Bill On Medicines Shortage

Germany Healthcare

GL

Gleiss Lutz

Germany As A Location For Pharmaceutical Businesses - Quo Vadis, 2024?

Germany Healthcare

TW

Taylor Wessing PartG mbB

Trademark Protection In The Life Sciences Business - Why Start-Ups And Founders Should Take Care

Germany Healthcare

TW

Taylor Wessing PartG mbB

OLG Nuremberg On The Unjustified Accusation Of Abuse Of Rights In The Case Of A Warning Letter

Germany Healthcare

TW

Taylor Wessing PartG mbB

OLG Hamburg On The Inadmissibility Of Issuing Pharmaceutical Prescriptions Over The Internet

Germany Healthcare

TW

Taylor Wessing PartG mbB

Important For Start-Ups: Confidentiality Agreements And Material Transfer Agreements (MTAs)

Germany Healthcare

TW

Taylor Wessing PartG mbB

Key Client Briefing: Einsatz künstlicher Intelligenz bei internen Untersuchungen

Germany Technology

OP

Oppenhoff

Regulierung der Barrierefreiheit, vor allem für Internetauftritte (E-Commerce-Webseiten)

Germany Finance

HM

Hengeler Mueller

Use Of Personal Data For AI Training Does Not Violate DMA According To Higher Regional Court Of Cologne

Germany Technology

PL

PwC Legal Germany

Key Client Briefing: Use Of Artificial Intelligence In Internal Investigations

Germany Technology

OP

Oppenhoff

IP Quick Tip: How To Protect UPC Patent Litigation With An Anti-Anti-Suit Injunction (2025) (Video)

BP

Bardehle Pagenberg

Food and Drugs Law

Second Medical Use Claims In The UPC System: Prerequisites And Mechanism Of Examination For Infringement

The Local Division of Düsseldorf is the first UPC panel to set out the prerequisites and establish essential factors for assessing infringement of second medical use claims in the UPC system. Its approach builds on the criteria developed by national (German) courts.

Germany Healthcare

BP

Bardehle Pagenberg

New German Government: Key Plans For The Life Sciences And Healthcare Sector

Following the election in February, the party leaderships of CDU, CSU and SPD have agreed on a coalition agreement titled "Responsibility for Germany".

Germany Healthcare

AO

A&O Shearman

New CJEU Ruling On The Borderline Between Medicinal Products And Medical Devices: Key Takeaways

The boundary between medicinal products and medical devices remains a recurring issue for companies developing or marketing borderline products and courts, which has already been the subject of numerous decisions.

Germany Healthcare

AO

A&O Shearman

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025

European Union Healthcare

AO

A&O Shearman

Council Approves EU Packaging Regulation ‒ Introduction Of Standardised Legal Framework For Entire Packaging Life Cycle And New Challenges For Market Participants

Germany Healthcare

N

Noerr

More Pills To Swallow – Antitrust Scrutiny In The Pharmaceutical Sector Remains High

European Union Anti-trust

HM

Hengeler Mueller

Central Division (Section Munich), Decision In Revocation Action, UPC 1/2023, UPC 14/2023

BP

Bardehle Pagenberg

Haribo's Gummy Bear: More Triumphs And Trials In Trade Mark Protection In The Food And Drink Industry

PC

Potter Clarkson

Dynamic German Cannabis Market: Rising Medical Use Today | Recreational Use Tomorrow

Germany Cannabis

GL

Gleiss Lutz

See more

Life Sciences, Biotechnology & Nanotechnology

Konsultation der EU-Kommission zu Hochrisiko-KI-Systemen: Kernpunkte für den Life Sciences- und Health Care-Sektor

Am 6. Juni 2025 hat die Europäische Kommission eine Konsultation zur Einstufung und Regulierung von Hochrisiko-KI-Systemen im Rahmen der...

Germany Technology

GT

Greenberg Traurig, LLP

EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of high-risk artificial intelligence (AI) systems under the EU Artificial Intelligence Act (AI Act).

European Union Healthcare

GT

Greenberg Traurig, LLP

Second Medical Use Claims In The UPC System: Prerequisites And Mechanism Of Examination For Infringement

The Local Division of Düsseldorf is the first UPC panel to set out the prerequisites and establish essential factors for assessing infringement of second medical use claims in the UPC system. Its approach builds on the criteria developed by national (German) courts.

Germany Healthcare

BP

Bardehle Pagenberg

New German Government: Key Plans For The Life Sciences And Healthcare Sector

Germany Healthcare

AO

A&O Shearman

New CJEU Ruling On The Borderline Between Medicinal Products And Medical Devices: Key Takeaways

Germany Healthcare

AO

A&O Shearman

The CJEU Issues New Ruling On Advertising Of Medicinal Products

Germany Media & IT

P

Plesner

RD Nordic-Baltic, January 21, 2025, Procedural Order On Costs For Access To Pleadings And Evidence, UPC_CFI_380/2023

BP

Bardehle Pagenberg

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025

European Union Healthcare

AO

A&O Shearman

CD Paris, 23 September 2024, Public Access To File, UPC_CFI_189/2024

European Union IP

BP

Bardehle Pagenberg

See more

Healthcare

Konsultation der EU-Kommission zu Hochrisiko-KI-Systemen: Kernpunkte für den Life Sciences- und Health Care-Sektor

Am 6. Juni 2025 hat die Europäische Kommission eine Konsultation zur Einstufung und Regulierung von Hochrisiko-KI-Systemen im Rahmen der...

Germany Technology

GT

Greenberg Traurig, LLP

EU Commission Consultation On High-Risk AI Systems: Key Points For Life Sciences And Health Care

On 6 June 2025, the European Commission launched a targeted stakeholder consultation on the classification and regulation of high-risk artificial intelligence (AI) systems under the EU Artificial Intelligence Act (AI Act).

European Union Healthcare

GT

Greenberg Traurig, LLP

New German Government: Key Plans For The Life Sciences And Healthcare Sector

Following the election in February, the party leaderships of CDU, CSU and SPD have agreed on a coalition agreement titled "Responsibility for Germany".

Germany Healthcare

AO

A&O Shearman

Wind Of Change - Are Medical Sick Leave Certificates Still Untouchable?

Germany Healthcare

L

Littler

Key Regulatory Changes Impacting The Healthcare Industry In The EU And Germany In 2025

European Union Healthcare

AO

A&O Shearman

LD Düsseldorf, September 6, 2024, Order Of The Court Of First Instance, UPC_CFI_165/2024 And UPC_CFI_166/2024

BP

Bardehle Pagenberg

ECJ Clarifies Further Questions On Compensation For Damages And Health Data

Germany Privacy

HK

HEUKING

The Digital Act: A Boost For Digitalisation In German Healthcare

Germany Healthcare

GL

Gleiss Lutz

Germany As A Location For Pharmaceutical Businesses - Quo Vadis, 2024?

Germany Healthcare

TW

Taylor Wessing PartG mbB

See more

Latest Videos

See more

Healthy Byte | Live From HIMSS 25! (Video)

AB

Alston & Bird

Zadłużona Służba Zdrowia

KHG Hupajlo Grzegorczyk & Partners

Lex Inside - L'Actualité Juridique - Émission Du 28 Juin 2024 (Video)

J

Jeantet

Episode #12 | European Health Data Space Regulation | 1 December 2022 (Video)

AM

Arendt & Medernach

Launch Of Our Medical Device Publication (Video)

WF

William Fry

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More